← All tickers

Is BHVN Worth Buying in 2026?

Biohaven Ltd.

STOCK PHARMACEUTICAL PREPARATIONS Updated 2026-06-14

Here’s whether Biohaven Ltd. (BHVN) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Neutral.

🔵
Neutral

Positives: above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+4.91% over 10 days); RSI 61 — healthy momentum range; 3-month momentum positive (+17.0%); rising volume confirms the move (1.15x 30d avg). Concerns: trading below the 200-day MA (long-term downtrend); weak 1-year return of -27.6%. Currently 39.2% off its 52-week high. Score: +2/7.

Ready to act on this? 📈 Trade on Webull

BHVN is trading below its 200-day MA ($11.62) — a key warning sign the longer-term trend is under pressure. An RSI of 61.4 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of -27.6% compares to +22.9% for SPY (trailed the market by 50.5%). The current 39.2% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.

$10,000 invested 1 year ago → $7,235 today
vs. S&P 500 (SPY) — same period trailed market by 50.5%

1-Year Price Chart

Daily candles
MA-50 MA-200 Up Down

Signal Check

✗Above 200-day MA ($11.62)
✓Above 50-day MA ($10.00)
✓RSI(14) neutral zone (30–70) — currently 61.4
✗Positive return (-27.6%)
!Within 10% of period high (−39.2%)
Period Range $11.28
$7.48 $18.57
RSI (14) 61.4
0 · OversoldOverbought · 100

Key Metrics

Price$11.28
Period Return-27.6%
Period High$18.57
Period Low$7.48
Drawdown−39.2%
MA-50$10.00
MA-200$11.62
RSI (14)61.4
Avg Volume (30d)2.6M
vs. SPYtrailed by 50.5%
Return Rank#936 of 1246

Trade BHVN

📈 Trade on Webull 📊 Trade on moomoo 💹 Interactive Brokers